Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Therapie|December 18, 2012
Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trialCaroline Scholtes, Patrice André, Christian Trépo, et al.
BMC Medical Research Methodology|November 16, 2013
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic reviewRémy Boussageon, Irène Supper, Sylvie Erpeldinger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 29, 2016
Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for SpondyloarthritisTheodora Bejan-Angoulvant, David Ternant, Fadela Daoued, et al.
RMD Open|November 18, 2021
Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trialsJohan Law-Wan, Marc-Antoine Sparfel, Sophie Derolez, et al.
Archives of Cardiovascular Diseases|May 26, 2024
Rationale and design of the French cohort of acute myocarditis diagnosed by cardiac magnetic resonance imaging (MyocarditIRM)Claire Bouleti, Clement Servoz, Benjamin Alos, et al.
JACC. Heart Failure|June 14, 2025
Contemporary Epidemiology, Management, and In-Hospital Outcomes of Acute Myocarditis: The Prospective Multicenter MyocarditIRM StudyClaire Bouleti, Theodora Bejan-Angoulvant, Clement Servoz, et al.
Targeted Oncology|July 15, 2018
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International RegistriesMarion Ferreira, Eric Pichon, Delphine Carmier, et al.
BMJ Open|September 11, 2024
Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocolElisa Dalix, Christian Marcelli, Theodora Bejan-Angoulvant, et al.
Medecine Sciences : M/S|January 7, 2020
[Monoclonal antibodies in cardiovascular diseases and metabolic disorders today]Denis Angoulvant, Atul Pathak
European Journal of Preventive Cardiology|September 23, 2025
Targets for Treatment and Optimal Strategies for Non-Pharmacological and Pharmacological Management of HypertensionBert-Jan H van den Born, Theodora Bejan-Angoulvant, Martino F Pengo, et al.
Pageof 23